| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.3M | -30.4% |
| R&D Expense | $435.1M | +3.6% |
| SG&A Expense | $116.5M | +29.0% |
| Operating Income | -$515.3M | -12.5% |
| Net Income | -$481.2M | -1.5% |
| EPS (Basic) | -$5.42 | +12.0% |
| EPS (Diluted) | -$5.42 | +12.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.7M | -56.7% |
| Short-term Investments | $685.5M | +2.4% |
| Accounts Receivable | $36.5M | +867.5% |
| Current Assets | $998.3M | -18.0% |
| Total Assets | $1.30B | -14.4% |
| Current Liabilities | $115.2M | -9.0% |
| Total Liabilities | $250.8M | -11.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$394.1M | -18.2% |
| Capital Expenditures | $14.0M | +3.1% |
| Investing Cash Flow | -$31.3M | -119.6% |
| Financing Cash Flow | $130.3M | -77.6% |
| Free Cash Flow | -$408.1M | -17.7% |
| Stockholders' Equity |
| $1.05B |
| -15.0% |